Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...

Dose-Response Relationship: Selectivity and Specificity

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...

Quantitative Aspects of Drug-Receptor Interaction

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...

The Equilibrium Binding Constant and Binding Strength

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:

Qualitative Analysis

Qualitative Analysis

Qualitative analysis is the process of identifying elements, ions, or compounds in an unknown sample. It is the first and most fundamental type of analysis based on the hierarchy of analytical goals. This hierarchy is significant as it provides a structured approach to scientific research, with qualitative analysis serving as the initial step, providing essential information before moving on to quantitative or other forms of analysis.
There are two main approaches to qualitative analysis:...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prediction of activity cliffs on the basis of images using convolutional neural networks.

Journal of computer-aided molecular design·2021

Same author

Evolution of assay interference concepts in drug discovery.

Expert opinion on drug discovery·2021

Same author

Adapting the DeepSARM approach for dual-target ligand design.

Journal of computer-aided molecular design·2021

Same author

Data set of competitive and allosteric protein kinase inhibitors confirmed by X-ray crystallography.

Data in brief·2021

Same author

Evaluation of multi-target deep neural network models for compound potency prediction under increasingly challenging test conditions.

Journal of computer-aided molecular design·2021

Same author

Predicting Isoform-Selective Carbonic Anhydrase Inhibitors via Machine Learning and Rationalizing Structural Features Important for Selectivity.

ACS omega·2021

Search research articles

Related Experiment Video

Updated: Jun 20, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

From structure-activity to structure-selectivity relationships: quantitative assessment, selectivity cliffs, and key

Lisa Peltason¹, Ye Hu, Jürgen Bajorath

¹Department of Life Science Informatics, B-IT, Rheinische Friedrich-Wilhelms-Universität Bonn, Germany.

|September 15, 2009

Summary

This summary is machine-generated.

This study introduces a novel data analysis method to systematically explore compound selectivity, crucial for drug optimization. It quantizes structure-selectivity relationships (SSRs) using network graphs, identifying key molecular determinants for target specificity.

More Related Videos

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Published on: June 6, 2025

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Related Experiment Videos

Last Updated: Jun 20, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Published on: June 6, 2025

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Area of Science:

Medicinal Chemistry
Computational Chemistry
Pharmacology

Background:

Lead optimization often focuses on single-target activity, neglecting poly-pharmacology.
Achieving target selectivity is a significant challenge due to compounds acting on multiple targets.

Purpose of the Study:

To develop a systematic and quantitative data analysis approach for exploring compound selectivity.
To establish methods for analyzing structure-selectivity relationships (SSRs).

Main Methods:

Utilized network-like similarity graphs (NSGs) to analyze compound similarity and selectivity data.
Adapted the SAR index (SARI) framework to quantify SSRs.
Analyzed differential activity data for compounds against four cathepsin thiol proteases.

Main Results:

Demonstrated that SSRs can be quantitatively described and categorized.
Identified local SSR environments and "selectivity cliffs" revealing selectivity determinants.
Characterized key compounds influencing single-target SARs and dual-target SSRs.

Conclusions:

The developed approach provides quantitative insights into SSRs and compound selectivity.
Analysis of selectivity cliffs highlights chemical modifications enhancing target specificity.
This method aids in designing selective compounds during drug discovery.